Clinical Trial Update: A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

View source ↗

Summary

Clinical trial update describing real-world use, safety, and effectiveness of oral upadacitinib in adults and adolescents (≥12 years) with atopic dermatitis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING